The second challenge we had was, in contrast to the smallpox vaccine, which was very stable, and a single dose protected you for life, the polio vaccine is incredibly fragile.
El segundo reto que afrontamos fue que, comparada con la viruela, la vacuna de la polio es supremamente delicada.